Expression of steroid receptor coactivator 3 in ovarian epithelial cancer is a poor prognostic factor and a marker for platinum resistance

被引：0
|
作者：
C Palmieri
O Gojis
B Rudraraju
C Stamp-Vincent
D Wilson
S Langdon
C Gourley
D Faratian
机构：
[1] Institute of translational Medicine,Department of Molecular and Clinical Cancer Medicine
[2] University of Liverpool,Division of Cancer
[3] Cancer Research UK Laboratories,Edinburgh Breakthrough Research Unit and Division of Pathology
[4] Imperial College London,undefined
[5] Du Cane Road,undefined
[6] London,undefined
[7] UK,undefined
[8] University of Edinburgh,undefined
[9] University of Edinburgh Cancer Research UK Centre,undefined
[10] Institute of Genetics and Molecular Medicine,undefined
[11] University of Edinburgh,undefined
来源：
British Journal of Cancer | 2013年 / 108卷
关键词：
ovarian cancer; SRC3; platinum; resistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2039 / 2044
页数：5
相关论文
共 50 条
  • [1] Expression of steroid receptor coactivator 3 in ovarian epithelial cancer is a poor prognostic factor and a marker for platinum resistance
    Palmieri, C.
    Gojis, O.
    Rudraraju, B.
    Stamp-Vincent, C.
    Wilson, D.
    Langdon, S.
    Gourley, C.
    Faratian, D.
    BRITISH JOURNAL OF CANCER, 2013, 108 (10) : 2039 - 2044
  • [2] Steroid and Xenobiotic Receptor (SXR) as a possible prognostic marker in epithelial ovarian cancer
    Yue, Xiaoni
    Akahira, Jun-ichi
    Utsunomiya, Hiroki
    Miki, Yasuhiro
    Takahashi, Naomi
    Niikura, Hitoshi
    Ito, Kiyoshi
    Sasano, Hironobu
    Okamura, Kunihiro
    Yaegashi, Nobuo
    PATHOLOGY INTERNATIONAL, 2010, 60 (05) : 400 - 406
  • [3] Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival
    Lenhard, Miriam
    Tereza, Lennerova
    Heublein, Sabine
    Ditsch, Nina
    Himsl, Isabelle
    Mayr, Doris
    Friese, Klaus
    Jeschke, Udo
    BMC CANCER, 2012, 12
  • [4] Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival
    Miriam Lenhard
    Lennerová Tereza
    Sabine Heublein
    Nina Ditsch
    Isabelle Himsl
    Doris Mayr
    Klaus Friese
    Udo Jeschke
    BMC Cancer, 12
  • [5] High expression of CETN2 is associated with platinum resistance and poor prognosis in epithelial ovarian cancer
    Pei-yuan Qiu
    Xi-han Deng
    Li Li
    Clinical and Translational Oncology, 2023, 25 : 1340 - 1352
  • [6] High expression of CETN2 is associated with platinum resistance and poor prognosis in epithelial ovarian cancer
    Qiu, Pei-yuan
    Deng, Xi-han
    Li, Li
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (05) : 1340 - 1352
  • [7] Expression of progesterone receptor is a favorable prognostic marker in ovarian cancer
    Lee, P
    Rosen, DG
    Zhu, CC
    Silva, EG
    Liu, JS
    GYNECOLOGIC ONCOLOGY, 2005, 96 (03) : 671 - 677
  • [8] The level of RECQL1 expression is a prognostic factor for epithelial ovarian cancer
    Matsushita, Yoko
    Yokoyama, Yoshihito
    Yoshida, Hidemi
    Osawa, Yuki
    Mizunuma, Makito
    Shigeto, Tatsuhiko
    Futagami, Masayuki
    Imaizumi, Tadaastu
    Mizunuma, Hideki
    JOURNAL OF OVARIAN RESEARCH, 2014, 7
  • [9] Expression of gonadotrophin releasing hormone receptor I is a favorable prognostic factor in epithelial ovarian cancer
    Wilkinson, S. J.
    Kucukmetin, A.
    Cross, P.
    Darby, S.
    Gnanapragasam, V. J.
    Calvert, A. H.
    Robson, C. N.
    Edmondson, R. J.
    HUMAN PATHOLOGY, 2008, 39 (08) : 1197 - 1204
  • [10] Association of Copper Transporter Expression with Platinum Resistance in Epithelial Ovarian Cancer
    Yoshida, Hiroyuki
    Teramae, Masatomo
    Yamauchi, Makoto
    Fukuda, Takeshi
    Yasui, Tomoyo
    Sumi, Toshiyuki
    Honda, Ken-Ichi
    Ishiko, Osamu
    ANTICANCER RESEARCH, 2013, 33 (04) : 1409 - 1414
12345